Clinical and Prognostic Features of Patients With Esophageal Cancer and Multiple Primary Cancers: A Retrospective Single-institution Study
- PMID: 28151796
- DOI: 10.1097/SLA.0000000000002118
Clinical and Prognostic Features of Patients With Esophageal Cancer and Multiple Primary Cancers: A Retrospective Single-institution Study
Abstract
Objective: To investigate the clinical and prognostic characteristics of patients with esophageal cancer and multiple primary cancers.
Summary background data: Patients with esophageal cancer frequently have multiple primary cancers, the presence of which may complicate physicians' decision-making because the clinical and prognostic features of such patients remain unknown.
Methods: This retrospective single-institution study included 538 consecutive patients who had undergone resection of esophageal cancer. The Cox proportional hazard model was used to compute the hazard ratio (HR) for mortality.
Results: At the time of surgery, 163 patients (30%) had multiple primary cancers (77, metachronous; 86, synchronous). Multiple primary cancers were significantly associated with alcohol use and tobacco smoking (Brinkman index). Patients with synchronous cancers had significantly shorter overall survival than those without multiple primary cancers (log-rank P = 0.032; univariate HR = 1.53, 95% confidence interval 1.02-2.17, P = 0.040; multivariate HR: 1.61; 95% confidence interval: 1.08-2.36; P = 0.020). Patients with metachronous cancers had similar prognoses to those without multiple primary cancers. The prognostic effect of synchronous cancers on overall survival was particularly prominent in patients with Stage I esophageal cancer (log-rank P = 0.0002).
Conclusions: Multiple primary cancers are associated with a history of tobacco and alcohol use, supporting the concept of field cancerization. Synchronous multiple primary cancers may be an independent predictor of poorer long-term survival in patients undergoing resection of esophageal cancers.
Comment in
-
Comment on "Clinical and Prognostic Features of Patients With Esophageal Cancer and Multiple Primary Cancers".Ann Surg. 2019 Jun;269(6):e75. doi: 10.1097/SLA.0000000000002833. Ann Surg. 2019. PMID: 31082925 No abstract available.
Similar articles
-
Incidence and risk factors of synchronous colorectal cancer in patients with esophageal cancer: an analysis of 480 consecutive colonoscopies before surgery.Int J Clin Oncol. 2016 Dec;21(6):1079-1084. doi: 10.1007/s10147-016-1015-8. Epub 2016 Jul 1. Int J Clin Oncol. 2016. PMID: 27368336
-
Safety and benefit of curative surgical resection for esophageal squamous cell cancer associated with multiple primary cancers.Eur J Surg Oncol. 2016 Mar;42(3):407-11. doi: 10.1016/j.ejso.2015.11.012. Epub 2015 Dec 10. Eur J Surg Oncol. 2016. PMID: 26733367
-
Prognostic Impact of Postoperative Complications in 502 Patients With Surgically Resected Esophageal Squamous Cell Carcinoma: A Retrospective Single-institution Study.Ann Surg. 2016 Aug;264(2):305-11. doi: 10.1097/SLA.0000000000001510. Ann Surg. 2016. PMID: 26670288
-
Rigid Esophagoscopy for Head and Neck Cancer Staging and the Incidence of Synchronous Esophageal Malignant Neoplasms.JAMA Otolaryngol Head Neck Surg. 2016 Jan;142(1):40-5. doi: 10.1001/jamaoto.2015.2815. JAMA Otolaryngol Head Neck Surg. 2016. PMID: 26633039 Review.
-
Preoperative sarcopenia is a predictor of poor prognosis of esophageal cancer after esophagectomy: a comprehensive systematic review and meta-analysis.Dis Esophagus. 2019 Mar 1;32(3):doy115. doi: 10.1093/dote/doy115. Dis Esophagus. 2019. PMID: 30496385
Cited by
-
Germline BRCA2 Truncating Mutation in Familial Esophageal Squamous Cell Carcinoma: A Case Controlled Study in China.Med Sci Monit. 2020 Jun 24;26:e923926. doi: 10.12659/MSM.923926. Med Sci Monit. 2020. PMID: 32579544 Free PMC article.
-
Comparison of efficacy and safety between neoadjuvant chemotherapy and neoadjuvant immune checkpoint inhibitors combined with chemotherapy for locally advanced esophageal squamous cell carcinoma: a systematic review and meta-analysis.Int J Surg. 2024 Jan 1;110(1):490-506. doi: 10.1097/JS9.0000000000000816. Int J Surg. 2024. PMID: 37800587 Free PMC article.
-
Discovery and validation of Hsa-microRNA-3665 promoter methylation as a potential biomarker for the prognosis of esophageal squaous cell carcinoma.Int J Clin Oncol. 2025 Feb;30(2):309-319. doi: 10.1007/s10147-024-02656-3. Epub 2024 Dec 4. Int J Clin Oncol. 2025. PMID: 39630213 Free PMC article.
-
Analysis of camrelizumab in neoadjuvant chemotherapy for esophageal cancer: A retrospective cohort study.Oncol Lett. 2025 Jul 17;30(4):449. doi: 10.3892/ol.2025.15195. eCollection 2025 Oct. Oncol Lett. 2025. PMID: 40747378 Free PMC article.
-
Clinical significance of sarcopenic dysphagia for patients with esophageal cancer undergoing esophagectomy: A review.Ann Gastroenterol Surg. 2022 Jul 28;6(6):738-745. doi: 10.1002/ags3.12603. eCollection 2022 Nov. Ann Gastroenterol Surg. 2022. PMID: 36338588 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical